RETREATMENTS WITH RITUXAN(TM) (RITUXIMAB, IDEC-C2B8) HAVE SIGNIFICANTEFFICACY, DO NOT CAUSE HAMA, AND ARE A VIABLE MINIMALLY TOXIC ALTERNATIVE IN RELAPSED OR REFRACTORY NON-HODGKINS-LYMPHOMA (NHL)

Authors
DAVIS T LEVY R WHITE CA MALONEY DG LINK B VELASQUEZ WS VARNS C GARDNER C GRILLOLOPEZ AJ
Citation
T. Davis et al., RETREATMENTS WITH RITUXAN(TM) (RITUXIMAB, IDEC-C2B8) HAVE SIGNIFICANTEFFICACY, DO NOT CAUSE HAMA, AND ARE A VIABLE MINIMALLY TOXIC ALTERNATIVE IN RELAPSED OR REFRACTORY NON-HODGKINS-LYMPHOMA (NHL), Blood, 90(10), 1997, pp. 2269-2269
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
90
Issue
10
Year of publication
1997
Part
1
Supplement
1
Pages
2269 - 2269
Database
ISI
SICI code
0006-4971(1997)90:10<2269:RWR(IH>2.0.ZU;2-Z